These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 2887420)
1. Mononitrates in combination with beta-blocker therapy in the treatment of severe angina pectoris. Svendsen JH; Amtorp O Drugs; 1987; 33 Suppl 4():122-4. PubMed ID: 2887420 [No Abstract] [Full Text] [Related]
2. Long term efficacy of a controlled-release formulation of isosorbide 5-mononitrate (Imdur) in angina patients receiving beta-blockers. Uusitalo A Drugs; 1987; 33 Suppl 4():111-7. PubMed ID: 2887418 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of controlled-release isosorbide-5-mononitrate as adjunctive treatment to beta-blocking agents in patients with stable angina pectoris. Svendsen JH; Aldershvile J; Abildgaard U; Amtorp O J Cardiovasc Pharmacol; 1989 Sep; 14(3):358-63. PubMed ID: 2476613 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of angina pectoris with beta-receptor blockaders a slow-releasing isosorbide dinitrate preparation]. Kappenberger L; Fellmann H; Nager F Schweiz Med Wochenschr; 1973 Dec; 103(50):1789-92. PubMed ID: 4149035 [No Abstract] [Full Text] [Related]
5. Mononitrates as monotherapy in the prophylactic treatment of angina pectoris. Rehnqvist N; Nyberg G; Carlens P; Lindström E; Lundman T; Nordlander R; Ulvenstam G; Aberg A; Aström H Drugs; 1987; 33 Suppl 4():100-3. PubMed ID: 3622313 [TBL] [Abstract][Full Text] [Related]
6. Abrupt withdrawal of isosorbide 5-mononitrate (Imdur) after long term treatment in stable angina pectoris. A preliminary report. Rehnqvist N; Olsson G; Engvall J; Rosenqvist U; Nyberg G; Aberg A; Ulvenstam G; Uusitalo A; Keyriläinen O; Härkönen R Drugs; 1987; 33 Suppl 4():118-21. PubMed ID: 2887419 [TBL] [Abstract][Full Text] [Related]
7. Nitrate therapy for stable angina pectoris. Parker JD; Parker JO N Engl J Med; 1998 Feb; 338(8):520-31. PubMed ID: 9468470 [No Abstract] [Full Text] [Related]
8. [Coronary therapeutic effectiveness of low-dose IS-5-MN in comparison with the combination IS-5-MH and metipranolol and placebo]. Müller G; Uberbacher HJ; Glocke M Med Welt; 1983 Mar; 34(10):321-7. PubMed ID: 6133205 [No Abstract] [Full Text] [Related]
9. Is isosorbide mononitrate better than the dinitrate? Drug Ther Bull; 1984 Jan; 22(2):7-8. PubMed ID: 6363029 [No Abstract] [Full Text] [Related]
10. [Effects of oral administration of subcontinuous doses of delayed-action isosorbide-5-mononitrate. Absence of tolerance]. Lai C; Onnis E; Orani E; Soro A; Pirisi R; Cherchi A Cardiologia; 1988 Nov; 33(11):1069-74. PubMed ID: 3076514 [No Abstract] [Full Text] [Related]
11. [Nitrates. The place in contemporary therapy of ischemic heart disease]. Martsevich SIu Kardiologiia; 2005; 45(7):69-72. PubMed ID: 16091666 [No Abstract] [Full Text] [Related]
12. [The treatment of angina pectoris with a fixed combination of a beta-adrenoceptor blocker and a long-acting nitrate (double-blind trial) (author's transl)]. Greif S; Roth F; Harnoncourt K Schweiz Rundsch Med Prax; 1977 Nov; 66(48):1554-9. PubMed ID: 337281 [No Abstract] [Full Text] [Related]
13. [Anti-angina action and tolerance of isosorbide-5-mononitrate or nifedipine in retard form]. Erlemeier HH; Kupper W; Lange S; Bleifeld W Z Kardiol; 1986; 75 Suppl 3():112-4. PubMed ID: 3541415 [TBL] [Abstract][Full Text] [Related]
14. N-acetylcysteine modifies the acute effects of isosorbide-5-mononitrate in angina pectoris patients evaluated by exercise testing. Svendsen JH; Klarlund K; Aldershvile J; Waldorff S J Cardiovasc Pharmacol; 1989 Feb; 13(2):320-3. PubMed ID: 2468964 [TBL] [Abstract][Full Text] [Related]
15. Comparison between felodipine and isosorbide mononitrate as adjunct to beta blockade in patients > 65 years of age with angina pectoris. de Vries RJ; Dunselman PH; van Veldhuisen DJ; van den Heuvel AF; Wielenga RP; Lie KI Am J Cardiol; 1994 Dec; 74(12):1201-6. PubMed ID: 7977090 [TBL] [Abstract][Full Text] [Related]
16. Use of nitrates in unstable angina pectoris. Conti CR Am J Cardiol; 1987 Nov; 60(15):31H-34H. PubMed ID: 2891289 [TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of long-acting anti-anginal drugs in the treatment of cardiovascular diseases]. Watanabe H; Kato K Kokyu To Junkan; 1990 Nov; 38(11):1081-9. PubMed ID: 1979885 [No Abstract] [Full Text] [Related]
18. [Ergometric study of the association of a beta-blocker and a nitrate derivative]. Jullien G Nouv Presse Med; 1978 Sep; 7(31):2727-31. PubMed ID: 30951 [No Abstract] [Full Text] [Related]
19. Tolerance induction during therapy with long-acting nitrates: how extensive is the "collateral damage"? Horowitz JD Cardiovasc Drugs Ther; 2004 Jan; 18(1):11-12. PubMed ID: 15228054 [No Abstract] [Full Text] [Related]
20. [Therapy of coronary disease]. Trenkwalder P; Lydtin H Dtsch Med Wochenschr; 1992 Jan; 117(1):37-8. PubMed ID: 1346102 [No Abstract] [Full Text] [Related] [Next] [New Search]